Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03659916

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Progressive Familial Intrahepatic Cholestasis Clinical Trial

Official title:
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of A4250 in Children With Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 2)

Clinical Trial Summary

Open Label Extension Study to evaluate long term safety and persistence of effect of A4250 in children with PFIC.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03659916
Study type Interventional
Source Ipsen
Contact
Status Active, not recruiting
Phase Phase 3
Start date September 28, 2018
Completion date March 31, 2025
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04729751 - A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS). Phase 2
Recruiting NCT05687474 - Baby Detect : Genomic Newborn Screening
Recruiting NCT04071197 - Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders N/A
Completed NCT02131623 - Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease
Completed NCT02963077 - A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 Phase 1
Completed NCT03082937 - An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects Phase 1
Recruiting NCT05704517 - Progressive Familial Intrahepatic Cholestasis in Indian Children - Establishing an Indian PFIC Registry
Enrolling by invitation NCT03930810 - NAtural Course and Prognosis of PFIC and Effect of Biliary Diversion
Approved for marketing NCT04483531 - Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis